Navigation Links
'InvoiceCHECK' Cuts Prescription Benefit Waste
Date:12/5/2007

Unique Product from TRICAST Eliminates Annual Audits & Contentious Audit

Recovery Attempts; Provides Ongoing Compliance

MILWAUKEE, Dec. 5 /PRNewswire/ -- InvoiceCHECK, an innovative forensic prescription claims audit designed to verify PBM claims billings for each invoice, has been introduced by TRICAST.

InvoiceCHECK replaces annual retrospective audits by auditing claims each time a company receives an invoice for its prescription benefit claims.

"Every time that an employer receives a bill, we run the claims on the invoice through our system to make sure the invoice is correct and the client has been properly billed," said Greg Rucinski, TRICAST President. "If there are any discrepancies in your contract pricing or your plan design, we find them every two weeks instead of letting them pile up over a year and then doing a big, retrospective audit."

This exciting new product uses TRICAST analytics and proprietary software applications to deliver significant value to employers who sponsor pharmacy benefits, including:

-- a basis for sarbanes oxley compliance and fiduciary accountability

-- no more annual retrospective audits

-- no more potentially contentious audit recovery attempts

-- on-going compliance with contract pricing and plan design

-- up-to-date and immediate financial reporting

"Think of it as preventive maintenance, like changing your oil every 3,000 miles," said John Adler, TRICAST National Practice Leader. "It costs about $20 to change your oil. What happens if you don't? Your engine is ruined."

"InvoiceCHECK provides a 'sentinel effect' to assure you that billing discrepancies are caught and corrected before they grow into a lot of money," Adler said. "Conversely, waiting to do an annual, retrospective audit often leads to a cumbersome, time-consuming, contentious process that identifies errors but does not result in total recovery of the identified dollars. If a plan sponsor still needs an annual audit, InvoiceCHECK is cumulative, so it also fills this need."

"InvoiceCHECK provides verification that your PBM is paying claims according to your contract pricing and plan design," added Rucinski. "This product is designed as a basis for communication in lieu of litigation. It is much easier to fix problems when they are a few weeks old."

"When we engage a client for on-going management, we typically identify 5-7% of waste in annual pharmacy benefit dollars," said Adler. "We think that InvoiceCHECK is a natural starting point to find process improvement opportunities and eliminate cost in-efficiencies."

About TRICAST

TRICAST, founded in Milwaukee in 1997, uses Rx and medical claims analysis to find, fix, and forecast risk in a variety of environments for self-funded employers, health plans, insurance companies, and Taft Hartley Funds. The company also provides a platform for ROI decision support and the communication strategies necessary to successfully implement them. The net result is lower annual trend and improved risk management.

TRICAST delivers data-driven cost control solutions every day and offers programs, products, and applications for pharmacy benefits that assist in controlling overall healthcare costs.

For business inquiries only, please contact John Adler, National Practice Leaderat 414.302.9733 or visit http://www.tricast.com. Media inquiries should be directed to Michael Beightol, Coyote Marsh & Associates, Inc., 847.277.7353.


'/>"/>
SOURCE Tricast, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Updates Prescription Guidelines for Blood Thinner
2. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
3. Prescription labels geared toward pharmacies, not patients
4. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
5. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
6. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
7. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
8. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
9. New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
10. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
11. New Pharmacys Owners Go Beyond Your Prescription
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: